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The bioelectrical signatures associated with regeneration, wound healing, development, and cancer are
changes in the polarization state of the cell that persist over long durations, and are mediated by ion
channel activity. To identify physiologically relevant bioelectrical changes that occur during normal
development of the sea urchin Lytechinus variegatus, we tested a range of ion channel inhibitors, and
thereby identiﬁed SCH28080, a chemical inhibitor of the Hþ/Kþ ATPase (HKA), as an inhibitor of ske-
letogenesis. In sea urchin embryos, the primary mesodermal lineage, the PMCs, produce biomineral in
response to signals from the ectoderm. However, in SCH28080-treated embryos, aside from randomi-
zation of the left-right axis, the ectoderm is normally speciﬁed and differentiated, indicating that the
block to skeletogenesis observed in SCH28080-treated embryos is PMC-speciﬁc. HKA inhibition did not
interfere with PMC speciﬁcation, and was sufﬁcient to block continuing biomineralization when embryos
were treated with SCH28080 after the initiation of skeletogenesis, indicating that HKA activity is con-
tinuously required during biomineralization. Ion concentrations and voltage potential were abnormal in
the PMCs in SCH28080-treated embryos, suggesting that these bioelectrical abnormalities prevent bio-
mineralization. Our results indicate that this effect is due to the inhibition of amorphous calcium car-
bonate precipitation within PMC vesicles.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Bioelectricity refers to long-term changes in the voltage po-
tential of cells, and the effect of these changes on biological sys-
tems (Levin, 2012, 2014). Bioelectricity plays a role in many pro-
cesses, including wound healing (Nuccitelli, 2003; Nuccitelli et al.,
2011; Wood, 2012), regeneration (Adams et al., 2007; Beane et al.,
2011; Nogi et al., 2005), and the development of organisms as
diverse as insects (Cole and Woodruff, 1997, 2000; Woodruff and
Telfer, 1980), sea urchins (Akasaka et al., 1997; Fujino et al., 1987;
Hibino et al., 2006; Mitsunaga et al., 1987), zebraﬁsh (Kawakami
et al., 2005; Nuckels et al., 2009), frogs, and chicks (Adams et al.,
2006; Fukumoto et al., 2005; Levin et al., 2002). Ion channels are
an excellent target for chemical inhibition, which is a relatively
simple way to uncover their roles in biological processes. To elu-
cidate further roles for bioelectrical changes in embryonic devel-
opment, we screened various ion channel and pump inhibitors for.effects on the development of sea urchin embryos, and found that
inhibition of the Hþ/Kþ ATPase (HKA) blocks skeletogenesis in
embryos of the sea urchin Lytechinus variegatus.
The embryonic skeleton is secreted by the primary mesench-
yme cells (PMCs). PMCs ingress into the blastocoel, then migrate
into a stereotypical pattern within the blastocoel. The PMCs are
arranged in a posterior ring around the blastopore with ven-
trolateral clusters that extend cords toward the anterior. PMCs are
directed to these positions by ectodermal cues (Armstrong et al.,
1993; Duloquin et al., 2007; Guss and Ettensohn, 1997); they
subsequently secrete the skeleton in a pattern that conforms to
this arrangement. Prior to the initiation of skeletogenesis, the
PMCs fuse, forming a continuous syncytial cable (Hodor and Et-
tensohn, 1998), and the skeletal biomineral is deposited into an
extracellular space surrounded by this syncytial membrane (Wilt
et al., 2008).
The sea urchin skeleton is composed of the calcium carbonate
mineral calcite and numerous associated proteins. The calcium in
the skeleton is taken up from sea water (Nakano et al., 1963; Wilt
et al., 2008) and carbonate is absorbed from sea water or gener-
ated by cellular metabolism (Stumpp et al., 2012). At least 40
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mineral in sea urchin larvae (Livingston et al., 2006; Wilt et al.,
2008); however, little is known about their speciﬁc functions. The
process of and mechanisms underlying biomineralization remain
incompletely understood, and the sea urchin offers a relatively
simple model in which to study this complex biological process.
The HKA is best known for its role in gastric acid secretion in
mammals (Sachs et al., 1976). Activity of this pump has also been
implicated in patterning of the left-right axis in frog, zebraﬁsh, and
chicken embryos (Gros et al., 2009; Kawakami et al., 2005; Levin
et al., 2002; Mendes et al., 2014), and in signaling events that
mediate head regeneration and regenerative tissue remodeling in
planaria (Beane et al., 2011, 2013; Nogi et al., 2005). Discriminating
the closely related HKA and NKA genes on the basis of sequence
alone is extremely challenging, and HKA genes have not beenFig. 1. SCH28080 treatment inhibits skeletogenesis. Lytechinus variegatus embryonic (DI
(48 h post-fertilization) after treatment with either vehicle (A) or SCH28080 (B–H) at th
blastula; TVP – thickened vegetal plate; MB – mesenchyme blastula; EG – early gastrulidentiﬁed in any sea urchin species to date. Chemical inhibitors
offer a means to evaluate the functional role of this ion pump
during sea urchin development. In this study, we show that HKA
activity is required for precipitation of amorphous calcium car-
bonate within PMC vesicles, establishing the mechanistic basis for
the block to biomineralization observed in HKA-inhibited
embryos.2. Results
2.1. SCH28080 is a potent inhibitor of skeletogenesis in the sea
urchin larva
We identiﬁed SCH28080, a competitive inhibitor of the HKAC, 1) and skeletal (birefringence, 2) morphology is shown at late pluteus larva stage
e indicated developmental stages. Abbreviations: Fert – fertilization; HB – hatched
a; LG – late gastrula.
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of skeletogenesis in sea urchin larvae (Fig. 1A-B). SCH28080 is
highly speciﬁc and does not inhibit the closely related Naþ/Kþ
ATPase (NKA) (Lyu and Farley, 1997). Consistent with this, skeletal
growth was similarly prevented in embryos treated with Ome-
prazole, another HKA inhibitor with a distinct mechanism of ac-
tion (Morii et al., 1990), while Ouabain, an inhibitor of the closely
related NKA, had no effect on skeletogenesis (Fig. S1). When
SCH28080 was added to Lytechinus variegatus (Lv) cultures prior to
PMC ingression (Fig. 1B–D), the resulting larvae initiated small ske-
letal spicules, as evidenced by bilateral birefringent dots at the nor-
mal sites of skeletogenesis in the PMC clusters. However, these spi-
cules failed to elongate or branch to produce a normal skeleton. The
most conspicuous defect in these embryos is the lack of skeletal
elongation; gastrulation appears to be normal (Fig. 1B–D). After PMC
ingression, embryos were not as sensitive to SCH28080 treatment,
and were capable of making some amount of primary skeleton
(Fig. 1E–F). SCH28080 treatment after the initiation of skeletogenesis
resulted in stunted but morphologically normal skeletons (Fig. 1G–
H). These results show that SCH28080 treatment blocks skeleto-
genesis even after it has been initiated, indicating that SCH28080
inhibits processes that are active during biomineralization. The
minimum effective dose of SCH28080 for preventing skeletogenesis
in Lv embryos is 125 mM, which is markedly higher than the 50 mM
dose reported to randomize the left/right axis in another sea urchin
species (Hibino et al., 2006). In our model, a 50 mMdose of SCH28080
was not sufﬁcient to prevent skeletogenesis (Fig. S1C), although it did
increase the incidence of left/right axis defects to 40% of embryos,
compared to 12% of control embryos (Fig. S2C–F). The higher dose of
125 mM increased the incidence of left/right axis defects further, to
61% of embryos (Fig. S2G–J).
2.2. Speciﬁcation and differentiation of the ectoderm are unaffected
in SCH28080-treated embryos
PMCs receive skeletal patterning information and biominer-
alization cues from the ectoderm (Armstrong et al., 1993; DuloquinFig. 2. Ectoderm dorsal-ventral speciﬁcation and differentiation is not perturbed by SC
ﬁxed at late gastrula stage and subjected to ﬂuorescent in situ hybridization (FISH) for d
Embryos ﬁxed at pluteus stage were stained for the ciliary band (A3, B3) or the neural ma
green). Insets show the corresponding DIC or phase contrast images; all embryos are pres
ventral view.et al., 2007; Guss and Ettensohn, 1997). Thus, a key question is
whether the lack of skeletogenesis in SCH28080-treated embryos
results from defects in the ectoderm. Fluorescent in-situ hy-
bridization (FISH) experiments were performed to assess the
speciﬁcation of the ectoderm using well-characterized genes in
the ectoderm gene regulatory network (GRN) (Ben-Tabou de-Leon
et al., 2013; Li et al., 2012; Saudemont et al., 2010; Su et al., 2009)
(Fig. 2). At late gastrula stage, chordin (Bradham et al., 2009), irxA
(McIntyre et al., 2013), lefty (Duboc et al., 2008), and tbx2/3 (Gross,
2003) expression was unchanged in SCH28080-treated embryos
compared to controls (Figs. 2A1-A2, B1-B2), indicating that dorsal-
ventral ectodermal speciﬁcation is normal in SCH28080-treated
embryos. VEGF is a growth factor secreted from the ectoderm
which is required for biomineralization (Duloquin et al., 2007).
Spatial expression of VEGF and its receptor, here referred to as
VEGFR, were unaffected in SCH28080-treated embryos compared
to DMSO-treated controls (Fig. S3). These results were corrobo-
rated by QPCR analysis (Fig. S4A-B). Together, these data indicate
that ectodermal dorsal-ventral speciﬁcation and VEGF signaling
are not perturbed in SCH28080-treated embryos.
To evaluate ectodermal differentiation, we labeled the ciliary
band and neurons in SCH28080-treated larvae (Fig. 2B3–B4). The
ciliary band is a default ectodermal state, and is spatially restricted
to a stripe between the dorsal and ventral territories via repression
by TGFß-mediated dorsal and ventral speciﬁcation (Yaguchi et al.,
2010) (Fig. 2A3). In SCH28080-treated embryos, the ciliary band is
a tightly restricted stripe (Fig. 2B3), indicating that the ectodermal
dorsal-ventral speciﬁcation occurs normally in embryos treated
with SCH28080. Neural development in the sea urchin larva is a
relatively late event indicative of ectodermal differentiation
(Burke, 1978). Synaptotagmin B (synB) is a pan-neural marker that
labels neurons positioned along the ciliary band (Fig. 2A4, red),
while a subset of anterior neurons are serotonergic (Fig. 2A4,
green). Both types of neurons are normally positioned in
SCH28080-treated embryos (Fig. 2B4), indicating that neural dif-
ferentiation and patterning are not impacted by SCH28080. Thus,
neither the speciﬁcation nor differentiation of the ectoderm isH28080 treatment. Embryos treated with either vehicle (A) or SCH28080 (B) were
orsal IrxA (A1, B1) or Tbx2/3 (A2, B2) and ventral Chordin (A1, B1) or Lefty (A2, B2).
rkers synaptotagmin B (A4, B4, red), which labels all neurons, and serotonin (A4, B4,
ented in vegetal views with ventral toward the top, except in B3, which is an en face
Fig. 3. PMC positioning is normal in SCH28080- and Omeprazole-treated embryos. Vehicle- (A), SCH28080- (B), and Omeprazole-treated embryos (C) were ﬁxed at late
gastrula stage and immunolabeled for PMCs. The corresponding phase contrast images are inset. The number of PMCs per embryo is shown for each treatment as
average7SEM.
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2.3. SCH28080 treatment impairs PMC syncytium formation but not
PMC speciﬁcation
At late gastrula stage, the PMCs in control embryos arrange
themselves in a posterior ring around the blastopore, with ven-
trolateral clusters that extend cords toward the anterior (Fig. 3A).
Embryos treated with SCH28080 (Fig. 3B) or Omeprazole (Fig. 3C)
also have a PMC ring-and-cords structure, although a few PMCs
exhibit perturbed positioning in each case. The number of PMCs
per embryo was not affected by either SCH28080 or Omeprazole
treatment (Fig. 3D), demonstrating that HKA inhibition does not
affect the number or positioning of PMCs at late gastrula stage.
We next assessed PMC syncytium formation by expressing GFP
in half of the PMCs, then determining whether the marker spread
to the remaining PMC complement (Fig. 4A). In vehicle-treated
embryos, GFP co-labeled nearly every PMC (Fig. 4B1–B3). In con-
trast, only 50% of the PMCs from the uninjected side of the
SCH28080-treated embryos became GFP positive (Fig. 4C1–C3),
indicating that syncytium formation is impaired by SCH28080
treatment; further, this effect was reproducible (Fig. 4D). Thus,
SCH28080 treatment partially inhibits PMC syncytium formation.Fig. 4. PMC syncytium formation is impaired in SCH28080-treated embryos. A. Schem
(C) were immunolabeled for PMCs (1) and GFP (2); overlays are shown in panel 3. Parti
cluster of PMCs, which are GFP-negative in the SCH28080-treated embryo. D. The num
mately 50% with SCH28080 treatment, shown as average7SEM.Given the effects on biomineralization and syncytium forma-
tion, we next evaluated the expression of members of the PMC
gene regulatory network (Raﬁq et al., 2012). Surprisingly, no
changes in localization or expression levels of these genes was
detected by in situ hybridization or qPCR analysis in SCH28080-
treated embryos (Fig. S4C,S5). We included several biominer-
alization genes, and these were also unaffected by SCH28080 (Fig.
S4D). These results demonstrate that the known PMC speciﬁcation
and differentiation networks are intact in SCH28080-treated
embryos.
2.4. PMC ion distributions are perturbed by SCH28080 treatment
We expected to observe bioelectrical changes in embryos
treated with SCH28080, because this drug acts as an ion pump
inhibitor. To conﬁrm and quantitate those effects, we used a range
of ﬂuorescent probes to detect cellular polarity and relative ion
concentrations (Fig. 5A-B). Measurements were taken at a range of
time points comprising PMC ingression, PMC migration, and gas-
trulation. First, relative polarization was measured using the vol-
tage-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine ox-
onol (DiBAC4(3)), or DiBAC (Adams and Levin, 2012; Epps et al.,
1994). The overall voltage potential in control PMCs exhibits onlyatic of the experimental design. B., C. Control (B) and SCH28080-treated embryos
al projections of each confocal z-stack are shown for clarity. Arrowhead indicates a
ber of uninjected GFP-positive PMCs (i.e., PMCs that fused) is reduced by approxi-
Fig. 5. SCH28080 treatment depolarizes PMCs and modulates ion concentrations. Exemplars of vehicle- (A) and SCH28080-treated (B) embryos at mesenchyme blastula
stage, and quantitative results (C) are shown for the indicator dyes DiBAC, which senses voltage (1), SNARF, which senses protons (2), CoroNa, which senses sodium ions (3),
and MEQ, which senses chloride ions (4). A., B. All panels are presented as single z slices from a confocal microscope with the indicated look-up-table applied. Arrow-heads
indicate PMCs. Insets show the corresponding phase images. C. The ﬂuorescence signal intensity within PMCs of vehicle- (blue) or SCH28080-treated (red) embryos is plotted
at the indicated developmental stages, as averages7SEM; the relative values are given in arbitrary ﬂuorescence units (AFU). Each data point represents measurements from
12 or more embryos, with the exception of three control points, which were measured in fewer embryos. Note that the y-axis in C4 is inverted, with low signal corresponding
to high chloride ion concentrations, since Cl- ions quench MEQ ﬂuorescence. Abbreviations are as in Fig. 1.
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PMCs in SCH28080-treated embryos are dramatically depolarized
compared to those in vehicle-treated embryos (Fig. 5A1, B1, C1).
This effect is pronounced at the early timepoints from thickenedvegetal plate through early gastrula stages, corresponding to the
ingression and migration of the PMCs. However, as gastrulation
proceeds, the polarization state of the PMCs in SCH28080-treated
embryos becomes comparable to that in controls (Fig. 5C1). Proton
D. Schatzberg et al. / Developmental Biology 406 (2015) 259–270264distributions were measured using the pH-sensitive dye 5-(and-
6)-carboxy SNARFs-1 acetoxymethyl ester acetate (SNARF)
(Bassnett et al., 1990; Buckler and Vaughan-Jones, 1990; Han and
Burgess, 2010). Control PMCs have a consistent pH over time,
while the PMCs in SCH28080-treated embryos have a relatively
acidic pH, or high proton concentration, at mesenchyme blastula
and early gastrula stages (Fig. 5A2, B2, C2). This is as expected,
since SCH28080 inhibits an Hþ exchanger. Although the HKA is an
electroneutral ion pump, it often works in tandem with Kþ efﬂux
channels to modulate membrane voltage (Aw et al., 2008; Beane
et al., 2011; Fujita et al., 2002; Lambrecht et al., 2005; Shibata
et al., 2006). The change in proton levels is thus consistent with
and can account for the relative depolarization observed at these
stages in SCH28080-treated embryos (Fig. 5C1). At midgastrula
stage, the pH is comparable between SCH28080-treated embryos
and controls, again matching the overall polarization changes asFig. 6. Low-calcium sea water phenocopies SCH28080-treatment. Embryonic (DIC, 1) a
washing into artiﬁcial sea water with normal (A) or reduced (B–H) levels of calcium atmeasured by DiBAC. Finally, sodium and chloride ion concentra-
tions were measured by the dyes CoroNa Green AM (CoroNa) and
6-methoxy-N-ethylquinolinium iodide (MEQ), respectively (Bi-
wersi and Verkman, 1991; Martin et al., 2005; Meier et al., 2006;
Woll et al., 1996). In control embryos, both sodium and chloride
ion levels decline following early gastrula stage. Both ions were
present at comparable levels in the PMCs of SCH28080-treated
and control embryos at early time points (Fig. 5A3–A4, B3-B4, C3-
C4). However, at mid-gastrula stage, neither ion concentration
declined in SCH28080-treated embryos (Fig. 5C3–C4). Thus, re-
lative depolarization and proton concentration are increased dur-
ing PMC ingression and migration in SCH28080-treated embryos.
Sodium and chloride ion concentrations increased (relative to
controls) only later as gastrulation proceeds, and concomitant
with the recovery of normal polarization and pH in SCH28080-
treated embryos, suggesting that the later changes in sodium andnd skeletal morphology (plane polarized light, 2) is shown at pluteus stage after
the indicated developmental stages. Abbreviations as in Fig. 1.
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ization and ion concentrations were also made for the ectoderm
(Fig. S6), and this tissue exhibits proﬁles that are similar to those
observed in the PMCs in both vehicle- and SCH28080-treated
embryos, indicating that SCH28080 affects ion distributions
throughout the embryo, and not solely in the PMCs. These data
suggest that the HKA is broadly expressed, and also indicate that
ectodermal dorsal-ventral speciﬁcation and differentiation is re-
latively refractory to these changes in ion concentrations.2.5. SCH28080 treatment is phenotypically consistent with in-
sufﬁcient calcium availability
SCH28080 treatment impairs skeletogenesis even when addedFig. 7. SCH28080treatment results in increased calcium levels in embryonic tissues, and
(A) and SCH28080-treated (B) embryos imaged with the calcium-sensitive ﬂuorescent d
ﬂuorescence (2), and magniﬁed views of the indicated region (3). In magniﬁed views
ﬂuorescence levels in the indicated tissues of late gastrula (LG) stage embryos treated wi
D. Numbers of puncta per PMC in vehicle- or SCH28080-treated embryos at the indicatto embryos after the initiation of skeletogenesis (Fig. 1G-H), im-
plying that SCH28080 treatment directly impacts the biominer-
alization process. One obvious possibility is that SCH28080 treat-
ment blocks calcium import into the embryo. Consistent with this
possibility, the effect of SCH28080 treatment is phenocopied by
developing embryos in sea water that contains 25% of the normal
calcium concentration (Fig. 6). Lower sea water calcium con-
centrations were not compatible with embryo survival, possibly
due to disruption of cadherins junctions (data not shown). Inter-
estingly, washing embryos into low-calcium sea water at different
developmental stages resulted in effects similar to treating with
SCH28080 at those same stages (compare Fig. 6 with Fig. 1). Nei-
ther of these treatments results in an abrupt halt to skeletogen-
esis; instead, biomineralization continues for a few hours,decreased numbers of calcium-rich puncta in the PMCs. A., B. Examples of vehicle-
ye calcein are shown as DIC images (1), confocal images of single z-slices of calcein
, the contrast has been increased to clarify the puncta. C. Quantitation of calcein
th vehicle or SCH28080, shown as average arbitrary ﬂuorescence units (AFU)7SEM.
ed stages, shown as average counts7SEM.
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stores may be depleted (Wilt et al., 2008). We thus hypothesized
that SCH28080 treatment prevents calcium accumulation in the
PMCs, thereby blocking skeletogenesis. We tested this hypothesis
by co-treating embryos with SCH28080 and the calcium ionophore
A23187, which permits free movement of calcium ions across cell
membranes. However, rather than rescuing the effects of
SCH28080, A23187 treatment had little if any impact on spicule
initiation in SCH28080-treated embryos and slightly retarded
skeletogenesis at high doses in controls (Fig. S7). These results
contradict the hypothesis and indicate that SCH28080 does not
block calcium import.
2.6. PMCs in embryos treated with SCH28080 have increased in-
tracellular calcium concentrations, but reduced numbers of calcium-
rich puncta
We next asked how calcium concentrations are affected in
SCH28080-treated embryos using the calcium-sensitive ﬂuor-
escent dye calcein AM (Pinsino et al., 2011; Vidavsky et al., 2014;
Wilt et al., 2008) (Fig. 7). Surprisingly, SCH28080-treated embryos
reproducibly possess relatively elevated calcium levels in all tis-
sues (Fig. 7A–C). Bright calcein puncta are visible within the PMCs
of control embryos (Fig. 7A3), which correspond to calcium-rich
vesicles that contain nanospheres of amorphous calcium carbo-
nate (ACC) (Vidavsky et al., 2014). SCH28080-treated embryos
have approximately half the number of puncta per PMC as control
embryos at late gastrula stage, when skeletogenesis is initiating
(Fig. 7A3, B3, D). This difference was more pronounced at pluteus
stage, since control embryos had increased numbers of puncta per
PMC, while SCH28080-treated embryos did not (Fig. 7D). These
data indicate that SCH28080 treatment, despite generally elevat-
ing calcium levels, blocks the accumulation of ACC vesicles in
PMCs. These results also imply that the reduced number of ACC
vesicles observed in the PMCs within SCH28080-treated embryos
is insufﬁcient to support biomineralization.3. Discussion
In this study, we use ion pump inhibitors to show that activity
of the HKA is required for skeletogenesis in the sea urchin embryo.
We demonstrate that treatment with the HKA inhibitor SCH28080
impairs PMC syncytium formation and prevents skeletogenesis.
Addition of the drug after the initiation of skeletogenesis is sufﬁ-
cient to prevent further growth of the skeleton, indicating that
ongoing HKA activity is required during biomineralization.
The randomization of the left-right axis we observed at low
doses of the inhibitor is consistent with previous studies using
SCH28080 and other HKA inhibitors in sea urchins (Duboc et al.,
2005; Hibino et al., 2006). The block to skeletogenesis at higher
doses was replicated in this study with Omeprazole, another HKA
inhibitor, and this phenotype is also consistent with previous
studies of HKA inhibition in sea urchins (Fujino et al., 1987; Mit-
sunaga et al., 1987). Although there are some concerns about non-
speciﬁc effects of SCH28080 on the NKA (Lyu and Farley, 1997),
NKA inhibition in the present study using Ouabain did not result in
a block to skeletogenesis in Lv embryos. Moreover, the effects we
observe are consistent with a speciﬁc effect on HKA activity, since
proton levels, but not sodium or chloride levels, are rapidly re-
sponsive to SCH28080. Pre-gastrular SCH28080-treated embryos
have a relatively high proton concentration compared to controls.
This matches the relative depolarization exhibited by SCH28080-
treated embryos compared to controls at these timepoints. During
gastrulation, proton concentration and overall polarization in
SCH28080-treated embryos become comparable to controls, whilesodium and chloride concentrations are increased in SCH28080-
treated embryos compared to controls. Because the NKA is ex-
pressed throughout the development of the embryo (data not
shown), it is unlikely that these relatively late changes to Naþ and
Cl concentrations represent off-target effects of the drug, and we
therefore interpret these late effects on sodium and chloride ions
as reﬂecting compensatory changes by which SCH28080-treated
embryos restore voltage and pH homeostasis. Interestingly, de-
spite the normal proton concentrations and voltage potential of
SCH28080-treated embryos at the end of gastrulation when ske-
letogenesis initiates, these embryos remain unable to undergo
biomineralization.
The voltage and ion concentration changes we observed in
SCH28080-treated embryos were present in the ectoderm as well
as the PMCs. Our results indicate that voltage changes in the ec-
toderm do not disrupt dorsal-ventral speciﬁcation. Based on the
expression of in situ markers, ciliary band and neural labeling, and
the appearance of bilateral spicule initiations, ectodermal dorsal-
ventral speciﬁcation and neural development appears to be nor-
mal in SCH28080-treated embryos. In contrast, in situs for left-
right markers indicate randomization of the left-right axis in
embryos treated with SCH28080, consistent with previous studies
(Duboc et al., 2005; Hibino et al., 2006). The results indicate that
the effects of HKA-mediated changes in voltage potential within
the ectoderm are limited to left-right axis speciﬁcation.
SCH28080- and Omeprazole-treated embryos exhibit a strong
block to biomineralization, which prompted us to evaluate VEGF
and VEGFR expression, since this signal-receptor pair is required
for biomineralization (Adomako-Ankomah and Ettensohn, 2013;
Duloquin et al., 2007; Knapp et al., 2012). Surprisingly, we found
that VEGF and VEGFR expression was normal in SCH28080-treated
embryos. This interesting result indicates that normal VEGF and
VEGFR expression is not sufﬁcient for skeletogenesis in embryos
lacking HKA activity. These results are consistent with a model in
which HKA activity functions downstream from VEGF signaling
within the PMCs, although it is also possible that the HKA operates
independently of VEGF.
Because we observed a complete loss of skeleton in embryos
treated with SCH28080 prior to PMC ingression, we measured
biomineralization genes such as SM30, SM50, and p16 (Cheers and
Ettensohn, 2005; Wilt et al., 2013; Wilt, 1999; Wilt et al., 2008),
and found that biomineralization genes are expressed at normal
levels in SCH28080-treated embryos. These unexpected results
indicate, ﬁrst, that PMC speciﬁcation does not require HKA activity,
and second, that biomineralization gene expression does not suf-
ﬁce for skeletogenesis. Because syncytium formation was inhibited
in SCH28080-treated embryos and the PMC GRN factor Twist is
required for PMC fusion (Wu et al., 2008), we assessed Twist ex-
pression, and found that Twist levels are also comparable in
SCH28080-treated and control embryos. In fact, we found no dif-
ferences in the expression of any genes in the well-described PMC
speciﬁcation gene regulatory network in SCH28080-treated em-
bryos. It remains unclear how syncytium formation is impaired by
HKA inhibition, but our results indicate that it is not via modula-
tion of the known PMC GRN. In comparison to the GRN describing
PMC speciﬁcation, the PMC differentiation GRN is relatively sparse.
Aside from Twist, no genes are known that impact PMC fusion;
thus, it is possible that SCH28080 inhibits the expression of a
currently unknown suite of PMC fusion genes. Thus, chemical
approaches that inhibit ion channels and pumps as used in the
present study may serve to highlight biological processes for
which portions of the GRN are relatively incomplete. Alternatively,
it is plausible that the defect in PMC fusion in SCH28080-treated
embryos reﬂects a direct biophysical constraint on the fusion
process itself, which may require a relatively hyperpolarized state
within the PMCs.
D. Schatzberg et al. / Developmental Biology 406 (2015) 259–270 267In the absence of both Twist and syncytium formation, skele-
togenesis is profoundly blocked (Wu et al., 2008); thus, it is pos-
sible that the impaired PMC fusion in SCH28080-treated embryos
contributes to the block to skeletogenesis therein, particularly in
embryos treated with SCH28080 prior to the fusion event. How-
ever, defective fusion cannot account for the inhibition of biomi-
neralization that occurs with SCH28080 treatment initiated sub-
sequent to syncytium formation.
Importantly, addition of SCH28080 after skeletogenesis has
begun prevents further biomineralization. Thus, biomineralization
requires continuous HKA activity. Notably, the block to skeleto-
genesis occurs with a delay, which suggests that the embryo be-
comes depleted of a component required for biomineralization.
While loss of external calcium phenocopies SCH28080 treatment
by also producing a delayed block to skeletogenesis, addition of a
calcium ionophore did not rescue SCH28080 treatment, indicating
that decreased calcium uptake does not explain the lack of ske-
leton production in SCH28080-treated embryos. We found, in-
stead, that SCH28080 treatment results in increased intracellular
calcium ion levels in the PMCs, along with decreased numbers of
calcium-rich puncta. These puncta represent vesicles of pre-
cipitated amorphous calcium carbonate (ACC) that is destined for
secretion onto the mineral matrix (Vidavsky et al., 2014). Thus,
calcium ions are stalled within PMCs in SCH28080-treated em-
bryos, and are unable to be precipitated and exported to the ske-
leton, accounting for the block to biomineralization observed with
HKA inhibition.
Intracellular precipitation of ACC generates protons, and re-
quires a buffering mechanism to proceed (McConnaughey and
Whelan, 1997; Stumpp et al., 2012). The mechanism used to buffer
this reaction in sea urchins has not been elucidated, although it
has been suggested that the HKA may play a role (Fujino et al.,
1987; Mitsunaga et al., 1987; Stumpp et al., 2012). Importantly, we
have shown that SCH28080-mediated acidiﬁcation of the in-
tracellular pH within PMCs is transient and returns to control le-
vels before skeletogenesis initiates (Fig. 5C2); thus, it seems un-
likely that PMC acidiﬁcation can account directly for the block to
ACC precipitation. We also found that SCH28080 treatment pro-
vokes a delayed increase in sodium and chloride ions (Fig. 5C3–
C4). It is possible that these late ion imbalances impair carbonate
transport, and that defective carbonate transport underlies the
block to ACC precipitation observed with HKA inhibition. Carbo-
nate ions are transported into cells largely by two mechanisms.
Anion exchangers exchange carbonate and chloride ions in an
electroneutral manner, while co-transporters mediate the move-
ment of carbonate and sodium ions in an electrogenic manner, in a
ratio of greater than 1:1 (sodium:carbonate). These are both pas-
sive processes, relying on existing ion gradients of sodium and
chloride to drive transport of carbonate ions (Romero et al., 2013;
Soleimani, 2013). Thus, it is likely that bicarbonate ion con-
centrations are perturbed in SCH28080-treated embryos, but it is
unclear whether they are increased or decreased, and to what
extent.
Human biomineralization shares many commonalities with the
process in sea urchins. Osteoblasts secrete collagen and other
matrix proteins to form a scaffold (Blair et al., 2011; van de Peppel
and van Leeuwen, 2014). Precipitation of hydroxyapatite, a calcium
phosphate mineral, begins in vesicles which bud from osteoblasts
to deliver mineral to the protein scaffold (Anderson, 2003). Pre-
cipitation of bone mineral releases protons, and requires a slightly
alkaline pH to proceed (Blair et al., 2011). It remains unknown how
osteoblasts buffer sites of biomineralization. Recent evidence
shows that adults on long-term HKA inhibitor therapy have an
elevated risk of osteoporosis, suggesting that biomineralization is
impaired by HKA inhibition (Fournier et al., 2009; Targownik et al.,
2008; Vestergaard et al., 2006; Yang et al., 2006). An importantquestion to address is whether this HKA-inhibitor-mediated defect
in biomineralization in humans results from acidiﬁcation at the
site of biomineral precipitation, or from imbalances in other ions
such as sodium and chloride, as is the case in the sea urchin
embryo.4. Conclusions
Bioelectrical changes are critical for many aspects of collective
cellular biology, including wound healing, regeneration, and de-
velopmental axis speciﬁcation. Here we show that a normal
bioelectrical signature is required for biomineralization of the sea
urchin larval skeleton by the skeletogenic primary mesenchyme
cells (PMCs). Inhibition of the Hþ/Kþ ATPase (HKA) during sea
urchin development prevents biomineralization of the calcium
carbonate endoskeleton. The PMCs normally form a syncytium
prior to skeletogenesis, and HKA inhibition impairs but does not
block syncytium formation. However, the defect in syncytium
formation cannot be responsible for the block to biomineraliza-
tion, since HKA activity is required continuously as biomineral is
produced.
We show that HKA inhibition blocks the intravesicular pre-
cipitation of amorphous calcium carbonate (ACC). Although the
precipitation of ACC is thought to be pH dependent, we show that
HKA inhibition results in only a transient decrease in intracellular
pH and concomitant depolarization of the PMCs. At the develop-
mental stages when biomineral is precipitated, pH homeostasis is
restored in the PMCs, while intracellular levels of sodium and
chloride ions are increased; we interpret these changes as com-
pensatory. We show that HKA inhibition does not impair calcium
uptake, but does inhibit ACC precipitation. We speculate that this
effect is mediated through perturbed uptake of carbonate ions
secondary to the compensatory changes in sodium and chloride
ion concentrations. These results show that bioelectrical home-
ostasis is required to support ACC precipitation and biominer-
alization. Importantly, we show that pH homeostasis alone is not
sufﬁcient to support biomineralization; this novel result indicates
that other ions must be maintained at appropriate levels for bio-
mineralization to proceed. The question remains whether this
requirement for bioelectrical homeostasis is conserved in other
organisms that undergo biomineralization.5. Materials and methods
5.1. Embryo culture, microinjection, drug treatments, and
photography
Adult Lytechinus variegatuswere obtained from either Reeftopia
(Florida) or the Duke University Marine Labs (North Carolina).
Gametes were harvested and zygotic microinjections were per-
formed by standard methods. mRNA was prepared using the
mMessage mMachine Kit (Ambion). SCH28080, Omeprazole,
Ouabain, and A23187 (Sigma) were resuspended in anhydrous
DMSO and added to cultures before the second cleavage unless
otherwise indicated. Dose-response experiments determined that
a minimum effective dose of 125 mM SCH28080 was necessary to
prevent skeletogenesis. This dose varied slightly with different
populations of embryos and different preparations of drug. Cal-
cium-free sea water was prepared (450 mM sodium chloride,
9 mM potassium chloride, 48 mM magnesium sulfate, 6 mM so-
dium bicarbonate) and mixed proportionally with normal artiﬁcial
sea water (480 mM sodium chloride, 10 mM potassium chloride,
26 mM magnesium chloride hexahydrate, 28 mM magnesium
sulfate, 14 mM calcium chloride, 2 mM sodium bicarbonate) for
D. Schatzberg et al. / Developmental Biology 406 (2015) 259–270268low-calcium sea water treatments. Embryos were imaged on an
Zeiss Axioplan microscope at 200 with DIC optics or with plane-
polarized light to visualize birefringent skeletons. In some cases,
the latter images are shown as montages of different focal planes
to depict the entire skeleton in focus.
5.2. In situ hybridization
In situ hybridization was carried out by standard methods.
Probes for LvChordin, LvTbx2/3, LvIrxA, LvVEGF, LvVEGFR, and
LvSoxE were previously described (Bradham et al., 2009; Gross,
2003; McIntyre et al., 2013; Piacentino et al., 2015; Walton et al.,
2009). Probes for LvLefty, LvPitx2, LvAlx1, LvErg, LvEts, LvFoxB,
LvSnail, LvTbr, and LvTwist were kind gifts from Dave McClay.
Sequences for these genes except LvLefty and LvPitx2 were pre-
viously described (Saunders and McClay, 2014). A full-length probe
for LvFoxO was generated from Lv late gastrula stage cDNA. Probes
were labeled with either digoxigenin (Roche) or DNP-11-UTP
(Perkin Elmer). Visualization was carried out either with BM Pur-
ple (Roche) or with Tyramide Signal Ampliﬁcation Plus kit (Perkin
Elmer) using either ﬂuorescein or Cy3. Embryos were imaged on a
Zeiss Axioplan microscope.
5.3. QPCRs
Total RNA was collected from cultures of DMSO- and
SCH28080-treated embryos at either hatched blastula or late
gastrula stage. RNA was isolated with Trizol (Life Technologies)
and precipitated with glycogen carrier (Ambion). Samples were
DNAse-treated (DNA-free, Ambion) before reverse transcription
using the TaqMan Reverse Transcription kit (Life Technologies).
QPCR was performed with SYBR Green PCR Master Mix (Applied
Biosystems) in an ABI 7900ht qPCR thermocycler. Each bar pre-
sented represents three biological replicates (each in triplicate,
nine total measurements). CT values were normalized to LvSetmar
expression, and are presented as average7SE relative to control.
Primer sequences are presented in Table ST1.
5.4. Immunoﬂuorescence
Immunoﬂuorescent labeling was performed as previously de-
scribed (Bradham et al., 2009). Primary antibodies were 295
(ciliary band), 1e11 (synaptotagmin B), anti-serotonin (Sigma), 6a9
(PMCs), and anti-GFP (Torrey Pines Biolabs). Secondary antibodies
from Jackson Labs were either Cy2 or Cy3 conjugated. Embryos
were imaged on an Olympus Fv10i laser scanning confocal mi-
croscope. Z-stacks were projected using Olympus software and full
projections are presented except in the case of Fig. 4, where partial
projections are shown to increase clarity.
5.5. Ion dyes and quantitations
A panel of ﬂuorescent ion-indicator dyes was used to assess ion
distributions. Bis-(1,3-dibutylbarbituric acid)trimethine oxonol
(DiBAC4(3)) (DiBAC, relative polarization), 5-(and-6)-carboxy
SNARFs-1 acetoxymethyl ester acetate (SNARF, pH), CoroNa Green
AM (CoroNa, sodium), 6-methoxy-N-ethylquinolinium iodide
(MEQ, chloride), and Calcein AM (calcein, calcium) were purchased
from Invitrogen. Dyes were used according to the manufacturer’s
instructions and embryos were imaged live on either an Olympus
Fv10i laser scanning confocal, Olympus DSU spinning disk con-
focal, or Olympus Fv1000 scanning confocal. Raw 16 bit images of
single z-slices were quantitated using a customMatlab script. Each
image was normalized to background ﬂuorescence levels by
sampling empty space at the corners of the image and dividing all
other signal intensities by this “zero” value. All comparisons weremade between groups of embryos imaged on the same microscope
with identical image acquisition settings. DiBAC measurements
were taken independently at each time point for matched groups
of vehicle- and SCH28080-treated embryos and the results were
normalized to a time-course of control embryos acquired with
consistent imaging parameters. SNARF images were collected at
two emission wavelengths, 580 nm and 640 nm. Raw images were
thresholded such that any pixel containing less than 0.5% of the
maximum intensity was set to 0. The ratio of the two images was
made using a custom ImageJ plugin created by modifying Ratio
Plus. The custom plugin deﬁnes any pixel equal to 0 for which
either the numerator or denominator is 0. This generated a ratio
image, which was quantitated in Matlab. Because the thresholding
step created images for which the background signal equaled 0,
the normalization-to-background step was omitted. Error bars
shown are standard errors.Author contributions
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